Effect of metoprolol and alprenolol on the metabolic, hormonal, and haemodynamic response to insulin-induced hypoglycaemia in hypertensive, insulin-dependent diabetics. 1982

J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund

Insulin hypoglycaemia was induced three times in 6 insulin-dependent, hypertensive diabetics: before instituting antihypertensive long-term treatment and after obtaining a satisfactory blood pressure with either alprenolol or metoprolol given in a randomized order. The blood glucose concentration (1.6-1.9 mmol/l) at which the hypoglycaemia necessitated intravenous administration of glucose was almost identical on all three occasions. During hypoglycaemia the systolic and diastolic blood pressures increased significantly by a mean maximal rise of 27/14 mmHg on alprenolol treatment, but remained unchanged on metoprolol. The responses of adrenaline, noradrenaline, cortisol, and growth hormone did not differ significantly on the three occasions. None of the beta-adrenergic drugs counteracted the early hormone defence mechanisms in hypoglycaemia and the signs of hypoglycaemia were not masked. The haemodynamic response was altered only by the non-selective (alprenolol) and not by the selective beta-adrenergic blocking agent (metoprolol).

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
September 1980, Metabolism: clinical and experimental,
J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
July 1998, Journal of internal medicine,
J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
October 1976, Diabetologia,
J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
December 1966, Lancet (London, England),
J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
February 1989, Clinical endocrinology,
J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
January 1988, Acta diabetologica latina,
J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
February 1982, Scandinavian journal of clinical and laboratory investigation,
J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
February 1987, Srpski arhiv za celokupno lekarstvo,
J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
September 1980, Metabolism: clinical and experimental,
J Ostman, and P Arner, and K Haglund, and A Juhlin-Dannfelt, and J Nowak, and A Wennlund
July 1987, Diabetes research (Edinburgh, Scotland),
Copied contents to your clipboard!